> Ketotifen — Mechanism, Trials & Evidence | OSMF

← All agents | ← Research tracker

Ketotifen

PubChem entry

Evidence Summary

Evidence Level: Anecdotal
Mechanism: Not specified
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Dual H1 + mast cell stabilizer. Long track record; obs MCAS series. 1-2mg BID. 4-8wk to effect. When H1 alone insufficient.

Related Conditions

MCAS (no page yet)

Key Studies / References